NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $271,154 | -3.7% | 2,662 | -4.6% | 0.16% | +13.6% |
Q2 2023 | $281,643 | +9.4% | 2,791 | -0.3% | 0.14% | -6.7% |
Q1 2023 | $257,419 | +2.1% | 2,798 | +0.6% | 0.15% | +7.9% |
Q4 2022 | $252,204 | +17.9% | 2,780 | +9.9% | 0.14% | -1.4% |
Q2 2022 | $214,000 | -11.6% | 2,529 | -8.5% | 0.14% | -33.2% |
Q1 2022 | $242,000 | +6.1% | 2,763 | +5.9% | 0.21% | +46.5% |
Q4 2021 | $228,000 | – | 2,610 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |